未登录

Y

Yuanying Fang

Jiangxi University of Traditional Chinese Medicine

H指数:17

被引数:839

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A pleiotropic NO-releasing butylphthalide derivative attenuates ischemic stroke by preserving blood-brain barrier integrity via the eNOS/Cav-1/ MMP-9 pathway

一种多效性NO释放型丁基苯酞衍生物通过eNOS/Cav-1/MMP-9通路保护血脑屏障完整性以减轻缺血性脑卒中

European Journal of Medicinal Chemistry

IF5.9

2026-08-010

PRE

Design, synthesis, and antidiabetic activities of 5-methoxypyrimidine derivatives targeting GPR119 and DPP-4

靶向GPR119和DPP-4的5-甲氧基嘧啶衍生物的设计、合成及抗糖尿病活性

Bioorganic & Medicinal Chemistry

IF3

2025-07-160

PRE

Potential edaravone/benzocyclopentenone derivatives alleviate cerebral ischemia reperfusion injury as neuroprotective agents

潜在的爱达拉酮/苯环戊烯酮衍生物作为神经保护剂可减轻脑缺血再灌注损伤

BIOORGANIC CHEMISTRY

IF4.7

2025-04-010

PRE

Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-05-013

PRE

Synthesis and Neuroprotective Evaluation of Substituted Indanone/Benzofuranone and Piperidine Hybrids

ACS CHEMICAL NEUROSCIENCE

IF3.9

2024-04-242

PRE

Rapid Formation of Intramolecular Disulfide Bridges using Light: An Efficient Method to Control the Conformation and Function of Bioactive Peptides

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2023-10-034

PRE

Dual functional antioxidant and butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis and evaluation of novel melatonin-alkylbenzylamine hybrids

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2023-01-0113

PRE

A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2022-11-0120

PRE

Design, synthesis and biological evaluation of novel pyrazolone derivatives as selective butyrylcholinesterase inhibitors with antioxidant activity against Alzheimer's disease

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2022-04-014

PRE

Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH

IF3.7

2022-03-1120

OAAI

Gramicidin-S-Inspired Cyclopeptidomimetics as Potent Membrane-Active Bactericidal Agents with Therapeutic Potential (vol 16, pg 368, 2021)

IF3.4

2022-01-100

OA

Recent Advances in the Medicinal Chemistry of Farnesoid X Receptor

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-12-1032

PRE

Synthesis of Halogenated 1,5-Diarylimidazoles and Their Inhibitory Effects on LPS-Induced PGE2 Production in RAW 264.7 Cells

IF4.6

2021-10-091

OAAI

Polymyxin B-inspired non-hemolytic tyrocidine A analogues with significantly enhanced activity against gram-negative bacteria: How cationicity impacts cell specificity and antibacterial mechanism

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-10-0113

PREAI

Nanocrystal-Loaded Micelles for the Enhanced In Vivo Circulation of Docetaxel

IF4.6

2021-07-2414

OAAI

GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present)

EXPERT OPINION ON THERAPEUTIC PATENTS

IF4.6

2021-05-1013

PREAI

Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-03-0117

PREAI

Gramicidin-S-Inspired Cyclopeptidomimetics as Potent Membrane-Active Bactericidal Agents with Therapeutic Potential

IF3.4

2020-10-164

OAAI

Fabrication of ultra-small nanocrystals by formation of hydrogen bonds: In vitro and in vivo evaluation

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2020-01-0125

PREAI

Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-b][1,4]oxazine derivatives as potent GPR 119 agonists

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2019-10-287

OAAI